Literature DB >> 22143830

The importance of whole body imaging in tumor-induced osteomalacia.

William H Chong1, Sahzene Yavuz, Shrita M Patel, Clara C Chen, Michael T Collins.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 22143830      PMCID： PMC3232632          DOI： 10.1210/jc.2011-1757

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  5 in total

Review 1.  Tumor-induced osteomalacia.

Authors:  William H Chong; Alfredo A Molinolo; Clara C Chen; Michael T Collins
Journal:  Endocr Relat Cancer       Date:  2011-06-08       Impact factor: 5.678

2.  PET/CT localization of phosphaturic mesenchymal neoplasm causing tumor-induced osteomalacia.

Authors:  Michael C Roarke; Ba D Nguyen
Journal:  Clin Nucl Med       Date:  2007-04       Impact factor: 7.794

3.  Oncogenic osteomalacia: exact tumor localization by co-registration of positron emission and computed tomography.

Authors:  Eric Hesse; Eckart Moessinger; Herbert Rosenthal; Florian Laenger; Georg Brabant; Thorsten Petrich; Klaus F Gratz; Leonard Bastian
Journal:  J Bone Miner Res       Date:  2007-01       Impact factor: 6.741

4.  Localisation of mesenchymal tumours by somatostatin receptor imaging.

Authors:  Suzanne M Jan de Beur; Elizabeth A Streeten; A Cahid Civelek; Edward F McCarthy; Liliana Uribe; Stephen J Marx; Olufunmilayo Onobrakpeya; Lawrence G Raisz; Nelson B Watts; Michael Sharon; Michael A Levine
Journal:  Lancet       Date:  2002-03-02       Impact factor: 79.321

5.  Selective venous catheterization for the localization of phosphaturic mesenchymal tumors.

Authors:  Panagiota Andreopoulou; Claudia E Dumitrescu; Marilyn H Kelly; Beth A Brillante; Carolee M Cutler Peck; Felasfa M Wodajo; Richard Chang; Michael T Collins
Journal:  J Bone Miner Res       Date:  2011-06       Impact factor: 6.741
  5 in total
  18 in total

Review 1.  Tumor-Induced Osteomalacia: an Up-to-Date Review.

Authors:  Anke H Hautmann; Matthias G Hautmann; Oliver Kölbl; Wolfgang Herr; Martin Fleck
Journal:  Curr Rheumatol Rep       Date:  2015-06       Impact factor: 4.592

2.  [An unusual cause of apparent oligoarthritis. A step back and a second look].

Authors:  C Fiehn; C Goerke
Journal:  Z Rheumatol       Date:  2014-05       Impact factor: 1.372

3.  [Osteomalacia-Clinical aspects, diagnostics and treatment].

Authors:  M Tiefenbach; M Scheel; A Maier; M Gehlen; M Schwarz-Eywill; M Werner; U Siebers-Renelt; M Hammer
Journal:  Z Rheumatol       Date:  2018-10       Impact factor: 1.372

4.  Diagnostic performance and impact on patient management of 68Ga-DOTA-TOC PET/CT for detecting osteomalacia-associated tumours.

Authors:  Marie Paquet; Mathieu Gauthé; Jules Zhang Yin; Valérie Nataf; Ophélie Bélissant; Philippe Orcel; Christian Roux; Jean-Noël Talbot; Françoise Montravers
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-03-12       Impact factor: 9.236

Review 5.  FGF23 and Associated Disorders of Phosphate Wasting.

Authors:  Anisha Gohil; Erik A Imel
Journal:  Pediatr Endocrinol Rev       Date:  2019-09

6.  Tumor localization and biochemical response to cure in tumor-induced osteomalacia.

Authors:  William H Chong; Panagiota Andreopoulou; Clara C Chen; James Reynolds; Lori Guthrie; Marilyn Kelly; Rachel I Gafni; Nisan Bhattacharyya; Alison M Boyce; Diala El-Maouche; Diana Ovejero Crespo; Richard Sherry; Richard Chang; Felasfa M Wodajo; Gad B Kletter; Andrew Dwyer; Michael T Collins
Journal:  J Bone Miner Res       Date:  2013-06       Impact factor: 6.741

Review 7.  New Therapies for Hypophosphatemia-Related to FGF23 Excess.

Authors:  Diana Athonvarangkul; Karl L Insogna
Journal:  Calcif Tissue Int       Date:  2020-06-05       Impact factor: 4.333

8.  FGF23 Producing Mesenchymal Tumor.

Authors:  Lucyna Papierska; Jarosław B Cwikła; Waldemar Misiorowski; Michał Rabijewski; Krzysztof Sikora; Hubert Wanyura
Journal:  Case Rep Endocrinol       Date:  2014-02-03

Review 9.  Renal rickets-practical approach.

Authors:  Manisha Sahay; Rakesh Sahay
Journal:  Indian J Endocrinol Metab       Date:  2013-10

10.  Tumor-Induced Osteomalacia: Increased Level of FGF-23 in a Patient with a Phosphaturic Mesenchymal Tumor at the Tibia Expressing Periostin.

Authors:  Anke H Hautmann; Josef Schroeder; Peter Wild; Matthias G Hautmann; Elisabeth Huber; Patrick Hoffstetter; Martin Fleck; Christiane Girlich
Journal:  Case Rep Endocrinol       Date:  2014-08-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.